aibioNXTS Nexentis Technologies Inc.
Nexentis Technologies (NXTS) news
Nexentis Technologies Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NXTS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Nexentis Technologies news
We have not published a story on Nexentis Technologies yet. When there is news, it will appear here.
Nexentis Technologies annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | $179,000 | $369,000 |
| Net income (loss) | -$4.0 million | -$5.2 million |
| Cash from operations | -$3.8 million | -$3.4 million |
| Cash and equivalents | $3.8 million | $1.9 million |
| Short-term investments | $239,000 | $234,000 |
Questions about Nexentis Technologies
What is the ticker symbol of Nexentis Technologies?
Nexentis Technologies Inc. trades under the ticker NXTS on NASDAQ.
Where is Nexentis Technologies listed?
Nexentis Technologies Inc. is listed on NASDAQ.
Which country or territory is Nexentis Technologies listed under?
Our directory records Nexentis Technologies Inc. under United States.
Does aibio.space cover Nexentis Technologies?
aibio.space lists Nexentis Technologies Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Is Nexentis Technologies profitable?
Nexentis Technologies Inc. reported a net loss of $4.0 million for the fiscal year ended Dec 31, 2025, and used $3.8 million of cash in operations, per its annual report to the SEC.
How much does Nexentis Technologies spend on research and development?
$179,000 in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Nexentis Technologies have?
$8.9 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: Nexentis Technologies
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Reported an unregistered sale of its securities. SEC Form 8-K (Items 3.02,5.02). Source
- Financings
Reported a financing. SEC Form 8-K (Items 1.01,9.01). Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source
- Legal
Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). Source
- Financings
Filed a final prospectus for a securities offering. SEC Form 424B5. Source
- Listings
Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.07). Source
Stock chart
Listing details
- Company
- Nexentis Technologies Inc.
- Ticker
- NXTS
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction